Technology | December 20, 2013

Siemens Receives FDA Clearance for Magnetom Prisma 3T MRI System

Scanner is designed for demanding clinical and research challenges

Siemens Receives FDA Clearance for Magnetom Prisma 3T MRI System

Siemens Healthcare has announced that the Food and Drug Administration (FDA) has cleared the Magnetom Prisma, a 3 Tesla (3T) magnetic resonance imaging (MRI) scanner capable of extraordinarily high spatial and temporal resolution to achieve outstanding image quality, particularly in highly demanding applications.

“Siemens is proud to add the Magnetom Prisma 3T scanner to our portfolio of world-class MRI systems,” said Gregory Sorensen, M.D., CEO of Siemens Healthcare North America. “With applications that display functional information and enable the visualization of details in the smallest anatomical structures, the MAGNETOM Prisma enables researchers to explore bold new territories and address their specific research needs.”

The Magnetom Prisma features XR Gradients, which combine 80 milliTesla per meter (mT/m) with a 200T-per-meter-per-second (T/m/s) slew rate to offer a configuration unavailable in any other commercial whole-body system. Complementing the extraordinary power of the Magnetom Prisma’s XR Gradients is the system’s exceptionally robust design. Precision is maintained throughout long, demanding applications such as functional MRI (fMRI). The power and endurance of the Magnetom Prisma’s XR Gradients fuel the system’s first-to-market Diffusion Spectrum Imaging (DSI) acquisition that enables the user to potentially resolve fine anatomical details of the brain such as crossing white-matter fibers.

Image quality is further enhanced by the Magnetom Prisma’s benchmark homogeneity and advanced shimming solutions that allow for finer, more effective compensation of patient-induced field disturbances. Together, these features provide the user with an outstanding basis for cardiac and body imaging, as well as applications such as spectroscopy.

The Magnetom Prisma possesses Siemens’ Dot (Day optimizing throughput) engines that enable exceptional consistency, which is crucial both in research applications and clinical work. The Dot engine brings automation and reproducibility to investigations across subjects, time points, and institutions, raising the integrity of longitudinal studies and multi-site research projects.

Siemens will offer onsite upgrades to the MAGNETOM Prisma to customers who have already installed the MAGNETOM Trio, a 3T MRI system with Tim (Total imaging matrix) technology.

For more information: www.siemens.com/healthcare

Related Content

An example of the MRI scans showing long-term and short-term survival indications. #MRI

An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — ...
A cutting-edge magnet resonance imaging (MRI) technique to detect iron deposits in different brain regions can track declines in thinking, memory and movement in people with Parkinson's disease #Parkinsons #MRI

Summary steps of the processing pipeline for QSM reconstruction (phase pre-processing and map estimation) and whole brain/regional analysis. ANTs, advanced normalisation tools; MP-RAGE, magnetisation-prepared, 3D, rapid, gradient-echo; MSDI, multi-scale dipole inversion; QSM, quantitative susceptibility mapping; ROI, region of interest; SWI, susceptibility weighted imaging.

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — A cutting-edge...
Two magnetic resonance imaging (MRI) findings — joint capsule edema and thickness at the axillary recess, specifically — proved useful in predicting stiff shoulder in patients with rotator cuff tears, according to an ahead-of-print article in the May issue of the American Journal of Roentgenology (AJR)

A: Oblique coronal fat-suppressed T2-weighted MR image shows normal hypointense joint capsule at axillary recess (arrow). Note full-thickness tear of supraspinatus tendon (arrowheads) B: Oblique sagittal proton density MR image shows preserved subcoracoid fat triangle (asterisk). Image courtesy of the American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | February 20, 2020
February 20, 2020 — Two ma...
Hyperfine Research, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the world’s first bedside Magnetic Resonance Imaging (MRI) system

Hyperfine's point-of-care MRI wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled via a wireless tablet. Photo courtesy of Business Wire

News | Magnetic Resonance Imaging (MRI) | February 12, 2020
February 12, 2020 — Hyperfine Research, Inc. announced that i
The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly

Image courtesy of GE Healthcare

News | Magnetic Resonance Imaging (MRI) | February 11, 2020
February 11, 2020 — The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly in the fo
Gadolinium-based contrast agents

UT Dallas faculty members who collaborated with Dr. Jeremiah Gassensmith (center, back), associate professor of chemistry and biochemistry, include Dr. Lloyd Lumata (left, back), assistant professor of physics, and Dr. Steven Nielsen, associate professor of chemistry. Chemistry graduate students in Gassensmith’s lab include (from left, front) Oliva Brohlin, Arezoo Shahrivarkevishahi and Laurel Hagge.

News | Contrast Media | February 06, 2020
February 6, 2020 — University of Texas at Dallas researchers
Qynapse, a medical technology company, announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its QyScore software
News | Information Technology | February 04, 2020
February 4, 2020 — Qynapse, a medical technology company, anno
RSNA 2019

RSNA 2019

Feature | Radiology Imaging | January 31, 2020 | By Greg Freiherr
The founder of Gonzo journalism thought
This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma

This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma. The quarter dose image on the left was obtained after the administration of 4 ml of MultiHance. Subsequently, an additional 12 ml of MultiHance was administered and the cumulative full dose image in the center was obtained. The image on the right was rendered following artificial intelligence processing of the 4 ml image using eGad genetic algorithms. This image has the quality of triple dose gadolinium even though only one quarter dose gadolinium was given.

Feature | Contrast Media Injectors | January 30, 2020 | By Matthew Kuhn, M.D., FACR
Gadolinium-based contrast agents (...